港股異動丨中國聯通漲近3% 一季度業績好於預期
格隆匯4月23日丨中國聯通(0762.HK)漲近3%,報5.03港元,總市值1539億港元。美銀髮表最新報告稱,聯通上季業績略好預期,料5G推出有助業務及股價表現。報告指出,聯通上季純利跌13.9%至32億元人民幣,比市場預期為佳,雖然2月內地疫情爆發,但在家工具號召下,令聯通2月服務收入升2.3%,隨著次季經驗復甦,估計上述收入增長會上升。該行亦稱,聯通推出5G後,令每月每户收入進一步下滑到40元人民幣,但隨著5G用户基礎擴大,最終聯通有望受惠。美銀續予聯通“買入”評級,因相信流動業務收入會持續增長,同時受惠策略合作伙伴推動,加上今年5G資本開支維持合理水平,續予10港元目標價不變。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.